Multiple sclerosis

Multiple sclerosis is a chronic inflammatory brain disease that is usually diagnosed between the ages of 20 and 40. Over time, MS becomes a neurodegenerative disease, leading to problems with vision, tingling, numbness, poor coordination, dizziness, difficulty walking, urinary incontinence, hearing loss, depression, and mobility. Most conventional treatments focus on the early stages of the disease. Unfortunately, there are few treatments for later stage MS.

To treat, or at least to stop the progression of MS, oxygen therapy in a hyperbaric chamber is widely used around the world. Hyperbaric oxygen therapy helps in the treatment of MS especially in the early stages, but it is also used by patients in the later stages.

In Great Britain, for example, more than 20,000 patients use it consistently. Up to a twenty-fold increase in the amount of oxygen flow to the brain leads to a number of positive effects, such as accelerating the repair of damaged tissue, removing or reducing inflammation not only in the brain, but also in the entire organism. Medical therapy with almost 100% oxygen is most recommended in the world at a chamber pressure of 1.5 ATA and a duration of therapy of 60-90 minutes. Foreign clinical studies are available, which we are happy to send to you upon request.